期刊文献+

突变乙型肝炎病毒核心蛋白的克隆及表达

Cloning of mutant core protein of hepatitis B virus and its expression
原文传递
导出
摘要 目的克隆并表达发生长片段缺失的HBV核心蛋白(HBV-C)基因,并对其进行DNA序列、蛋白质结构和抗原性分析。方法采用PCR方法从1株野生型HBV基因组中扩增得到发生长片段缺失的HBV-C基因,克隆至pUCm—T质粒,进行测序、同源性比较和蛋白质结构分析;再将基因编码区克隆至原核表达载体pET-28a,构建含HBVC基因的重组表达质粒,转化至大肠埃希菌BL21中进行诱导表达并检测其抗原性。结果PCR扩增出的HBV-C基因长度经序列分析表明,其核苷酸序列缺失了220bp至317bp之间的98个碱基,造成从第74个氨基酸起发生移码突变并失去了抗原性。结论成功克隆和表达了发生长片段缺失的HBVC基因。 Objective and to perform DNA sequen (HBV-C) gene with long fr strain of wild type HBV, w of homology and protein st To clone and express mutant core protein of hepatitis B virus (HBV), cing, protein structure and antigenicity analyses. Methods The HBV core agment deletion was amplified by polymerase chain reaction (PCR) from a hich was cloned into pUCm-T vector. Then DNA sequencing and analysis ructure were performed. In addition, inserted into the expression constructed, which was then analysis. Results The fragme the sequence, which resulted vector pET-28a and the recombin the coding region of HBV-C was ant plasmid pET-28a-HBV-C was transformed into E. coli BL21 for expression and the antigenicity nt amplified by PCR was 98 hp deletion hetween 220 hp and 317 hp of in frame shift mutation from amino acid 74 and loss of antigenicity. Conclusion The HBV-C gene with long fragment deletion is cloned and expressed successfully.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2009年第11期650-652,共3页 Chinese Journal of Infectious Diseases
关键词 肝炎病毒 乙型 病毒核心蛋白质类 基因 病毒 基因表达 基因缺失 克隆 分子 突变 Hepatitis B virus Viral core proteins Genes, viral Gene expression Gene deletion Cloning, molecular Mutation
  • 相关文献

参考文献2

二级参考文献20

  • 1Kim JW, Lee HS, Woo GH, et al. Fatal submassive hepatic necrosis associated with tyrosine- methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy. Clin Infect Dis, 2001, 33: 403-405. 被引量:1
  • 2Lin X, Yuan ZH, Wu L, et al. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol, 2001, 75:11827-11833. 被引量:1
  • 3Allen MI, Deslauriers M, Andrew CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology, 1998, 27:1670-1677. 被引量:1
  • 4Liu C J, Chen PJ, Lai MY, et al. Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences.Heoatology, 2001,34 : 583-589. 被引量:1
  • 5Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replicationd efective. Hepatology, 1998,27:628-633. 被引量:1
  • 6Boek CT, Tillmann, HL, Torresi J, et al. Selection of hepatitis B virus polyrnerase mutants with enhanced replication by tamivudine treatment after liver transplantation. Gastroenterology,2002, 122: 264-273. 被引量:1
  • 7Oho SK, Karo N, Shiratori Y, et al. The polymerase L528M mutation cooperates with nucleotide binding-site mutations increasing hepatitis B virus replication and drug resistance. J Clin Invest, 2001,107:449-455. 被引量:1
  • 8Pollicino T, Zanetti AR, Cacciola I, et al. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology, 1997, 26:495-499. 被引量:1
  • 9Omata M, Ehato T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med, 1991, 324 : 1699-1704. 被引量:1
  • 10Neau D, Schvoerer E, Robert D, et al. Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient. J infect, 2000,41:192-194. 被引量:1

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部